GLS and cancer: The enzyme GLS1, enabling further processing of Gln and its incorporation into various pathways, was reported as significantly upregulated in a broad spectrum of cancers, including breast [75,76,77], prostate [78,79,80], colorectal [81], and lung [82] cancers, and was shown to be crucial for cancer cell fitness.